Literature DB >> 26681488

Coffee or Tea, Hot or Cold, Are Not Associated With Risk of Barrett's Esophagus.

Krishna C Sajja1, Hashem B El-Serag2, Aaron P Thrift3.   

Abstract

Epidemiologic data regarding coffee and tea consumption and risk of esophageal inflammation, Barrett's esophagus (BE), and adenocarcinoma are sparse and inconclusive. This study examined the association between consumption of tea or coffee with risk of BE. We conducted a cross-sectional study among US veterans, comparing 310 patients with histologically confirmed BE with 1728 individuals with no endoscopic or histopathologic features of BE (controls). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression models. In univariate models, we found a statistically significant association between risk of BE and consumption of coffee (OR, 1.41; 95% CI, 1.06-1.87) or tea (OR, 1.34; 95% CI, 1.05-1.71). However, in multivariate analysis, in which models were adjusted for confounders including sex and race, we found no association between risk of BE and consumption of coffee (adjusted OR, 1.04; 95% CI, 0.76-1.42) or tea (adjusted OR, 1.11; 95% CI, 0.85-1.44). These data do not support an association between consumption of coffee or tea and the risk of BE. It is unlikely that avoidance of coffee or tea will protect against BE.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caffeine; Decaffeinated; EAC; Epidemiology; Risk Factors

Mesh:

Substances:

Year:  2015        PMID: 26681488      PMCID: PMC4837040          DOI: 10.1016/j.cgh.2015.12.007

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  8 in total

1.  Prevalence of Barrett's esophagus in the general population: an endoscopic study.

Authors:  Jukka Ronkainen; Pertti Aro; Tom Storskrubb; Sven-Erik Johansson; Tore Lind; Elisabeth Bolling-Sternevald; Michael Vieth; Manfred Stolte; Nicholas J Talley; Lars Agréus
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

2.  Esophageal carcinoma.

Authors:  Anil Rustgi; Hashem B El-Serag
Journal:  N Engl J Med       Date:  2015-04-09       Impact factor: 91.245

3.  Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study.

Authors:  J S Ren; N D Freedman; F Kamangar; S M Dawsey; A R Hollenbeck; A Schatzkin; C C Abnet
Journal:  Eur J Cancer       Date:  2010-04-13       Impact factor: 9.162

4.  Inhibitory effect of coffee on lower esophageal sphincter pressure.

Authors:  F B Thomas; J T Steinbaugh; J J Fromkes; H S Mekhjian; J H Caldwell
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

5.  Association between coffee intake and gastroesophageal reflux disease: a meta-analysis.

Authors:  J Kim; S-W Oh; S-K Myung; H Kwon; C Lee; J M Yun; H K Lee
Journal:  Dis Esophagus       Date:  2013-06-24       Impact factor: 3.429

6.  Gastric acid secretion and lower-esophageal-sphincter pressure in response to coffee and caffeine.

Authors:  S Cohen; G H Booth
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

7.  The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends.

Authors:  A P Thrift; D C Whiteman
Journal:  Ann Oncol       Date:  2012-07-30       Impact factor: 32.976

8.  Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study.

Authors:  Raul Zamora-Ros; Leila Luján-Barroso; H Bas Bueno-de-Mesquita; Vincent K Dik; Heiner Boeing; Annika Steffen; Anne Tjønneland; Anja Olsen; Bodil Hammer Bech; Kim Overvad; Marie-Christine Boutron-Ruault; Antoine Racine; Guy Fagherazzi; Tilman Kuhn; Verena Katzke; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Rosario Tumino; Salvatore Panico; Paolo Vineis; Sara Grioni; Domenico Palli; Elisabete Weiderpass; Guri Skeie; José María Huerta; María-José Sánchez; Marcial Argüelles; Pilar Amiano; Eva Ardanaz; Lena Nilsson; Bengt Wallner; Björn Lindkvist; Peter Wallström; Petra H M Peeters; Timothy J Key; Kay-Thee Khaw; Nicholas J Wareham; Heinz Freisling; Magdalena Stepien; Pietro Ferrari; Marc J Gunter; Neil Murphy; Elio Riboli; Carlos A González
Journal:  Int J Cancer       Date:  2014-02-28       Impact factor: 7.396

  8 in total
  6 in total

1.  Association between coffee or tea drinking and Barrett's esophagus or esophagitis: an Italian study.

Authors:  R A Filiberti; V Fontana; A De Ceglie; S Blanchi; E Grossi; D Della Casa; T Lacchin; M De Matthaeis; O Ignomirelli; R Cappiello; A Rosa; M Foti; F Laterza; V D'Onofrio; G Iaquinto; M Conio
Journal:  Eur J Clin Nutr       Date:  2017-05-10       Impact factor: 4.016

2.  Association between tea consumption and gastroesophageal reflux disease: A meta-analysis.

Authors:  Hongying Cao; Xiaoyi Huang; Xiaosong Zhi; Cuihong Han; Liang Li; Yuyi Li
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

Review 3.  Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain-Gut Axis.

Authors:  Amaia Iriondo-DeHond; José Antonio Uranga; Maria Dolores Del Castillo; Raquel Abalo
Journal:  Nutrients       Date:  2020-12-29       Impact factor: 5.717

4.  Tea and Recurrent Clostridium difficile Infection.

Authors:  Martin Oman Evans Ii; Brad Starley; Jack Carl Galagan; Joseph Michael Yabes; Sara Evans; Joseph John Salama
Journal:  Gastroenterol Res Pract       Date:  2016-08-29       Impact factor: 2.260

Review 5.  Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update.

Authors:  Astrid Nehlig
Journal:  Nutrients       Date:  2022-01-17       Impact factor: 5.717

6.  Lifestyle interventions can reduce the risk of Barrett's esophagus: a systematic review and meta-analysis of 62 studies involving 250,157 participants.

Authors:  Zhanwei Zhao; Zifang Yin; Chaojun Zhang
Journal:  Cancer Med       Date:  2021-06-15       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.